Log In
Print
BCIQ
Print
Print this Print this
 

MDDScore

  Manage Alerts
Collapse Summary General Information
Company Ridge Diagnostics Inc.
DescriptionBlood-based test that utilizes immunoassay technology and biomarker hypermapping (BHyperMap) and measures 10 biomarker levels to determine if a patient has major depressive disoder (MDD)
Molecular Target
Mechanism of ActionDiagnostic
Latest Stage of DevelopmentMarketed
IndicationNeurology, Diagnostic
Partner

Ameritox Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today